Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Shares Issued (2016 - 2025)

Enanta Pharmaceuticals (ENTA) has disclosed Shares Issued for 14 consecutive years, with $141000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 50.0% year-over-year to $141000.0, compared with a TTM value of $192000.0 through Dec 2025, down 20.33%, and an annual FY2025 reading of $145000.0, down 1.36% over the prior year.
  • Shares Issued was $141000.0 for Q4 2025 at Enanta Pharmaceuticals, up from $51000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $10.4 million in Q4 2021 and bottomed at $28000.0 in Q2 2024.
  • Average Shares Issued over 5 years is $1.7 million, with a median of $784000.0 recorded in 2021.
  • The sharpest move saw Shares Issued skyrocketed 1149.58% in 2021, then plummeted 95.15% in 2023.
  • Year by year, Shares Issued stood at $10.4 million in 2021, then crashed by 89.18% to $1.1 million in 2022, then crashed by 82.24% to $200000.0 in 2023, then crashed by 53.0% to $94000.0 in 2024, then soared by 50.0% to $141000.0 in 2025.
  • Business Quant data shows Shares Issued for ENTA at $141000.0 in Q4 2025, $51000.0 in Q3 2025, and $94000.0 in Q4 2024.